Stock Events

Stock Events

Protara Therapeutics 

€3.46
39
+€0.12+3.72% Thursday 06:02

Statistics

Day High
0
Day Low
0
52W High
6.4
52W Low
2.4
Volume
0
Avg. Volume
17
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q1 2026
Next
-0.31
-0.3
-0.28
-0.26
Expected EPS
-0.2829803232
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1KPA.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences operates in similar therapeutic areas, including oncology, which competes with Protara's cancer-focused therapies.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb offers a range of oncology treatments that directly compete with Protara's cancer drug pipeline.
Merck
MRK
Mkt Cap294.03B
Merck is known for its strong presence in the oncology market, competing with Protara's cancer therapies.
AMGEN
AMGN
Mkt Cap191.7B
Amgen focuses on innovative treatments in areas like oncology, posing competition to Protara's therapeutic approaches.
Pfizer
PFE
Mkt Cap149.38B
Pfizer has a broad portfolio of oncology drugs that compete with Protara's developments in cancer treatment.
Novartis
NVS
Mkt Cap292.07B
Novartis is a leading pharmaceutical company with a strong emphasis on oncology, competing with Protara's cancer therapies.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie has a growing oncology segment that competes with Protara's focus on cancer therapeutics.
Roche
RHHBY
Mkt Cap332.67B
Roche Holding AG, through its Genentech subsidiary, competes in the oncology space, directly challenging Protara's market.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca has a significant presence in oncology, with a portfolio that competes with Protara's cancer treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Regeneron Pharmaceuticals, known for its innovative biotechnology, competes in the development of cancer therapies similar to Protara's focus.

About

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.
Show more...
CEO
ISIN
US74365U1079

Listings

XNAS
US
TARA
STU
DE
1KPA.STU
MU
DE
1KPA.MU
F
DE
1KPA.F

0 Comments

Share your thoughts

FAQ

What is Protara Therapeutics stock price today?▼
The current price of 1KPA.MU is €3.46 EUR — it has increased by +3.72% in the past 24 hours. Watch Protara Therapeutics stock price performance more closely on the chart.
What is Protara Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Protara Therapeutics stocks are traded under the ticker 1KPA.MU.
Is Protara Therapeutics stock price growing?▼
1KPA.MU stock has risen by +7.59% compared to the previous week, the month change is a -14.11% fall, over the last year Protara Therapeutics has showed a +30.98% increase.
When is the next Protara Therapeutics earnings date?▼
Protara Therapeutics is going to release the next earnings report on July 30, 2026.
What were Protara Therapeutics earnings last quarter?▼
1KPA.MU earnings for the last quarter are -0.26 EUR per share, whereas the estimation was -0.31 EUR resulting in a +15.89% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Protara Therapeutics located?▼
Protara Therapeutics operates in the Other sector.
When did Protara Therapeutics complete a stock split?▼
Protara Therapeutics has not had any recent stock splits.